This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
at Northwestern University—has developed novel technology with the potential to change the future of drugdelivery. A team of scientists—led by Yamin Zhang, Ph.D., and Colin Franz, MD, Ph.D., at Shirley Ryan AbilityLab and John Rogers, Ph.D.,
Subcutaneous Medications Delivery has Steadily Gained Traction Over the Last Few Years With more than 90 approved products and over 240 clinical candidates, the field has evolved significantly as several stakeholders have sustained innovative research in the domain.
Stakeholders Involved in intranasal therapeutics and drugdelivery domain. Based on our research maximum number of players are located in North America (80%), followed by Europe and Asia-Pacific & RoW (5%, each). Intranasal Therapeutics and DrugDeliverySystems. Our Social Media Platform. Web: [link].
Future Perspectives Owing to various advantages offered by liposomes, advanced liposome technologies are being developed to fully substructure the therapeutic applications of liposomes and extensive research is being conducted to develop methods for liposomal formulation with high level of purity and sensitivity.
Global Transdermal DrugDeliverySystems Market Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 – ResearchAndMarkets.com Global Transdermal DrugDeliverySystems Market Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 … Continue (..)
AMR and multi-drug resistance are said to result in the deaths of more than five million people per year. Nine universities and research institutes, along with seven medical and industry partners, will work on the IN-ARMOR project across nine EU countries.
In a promising advancement, scientists from the University of North Carolina at Chapel Hill and Emory University have developed a novel drugdeliverysystem using synthetic amyloid beta (AÎ) peptides.
Ceapro has extended a partnership underway to carry out a further research project with McMaster University for developing an inhalable immuno-therapeutic/-prophylactic for Covid-19-induced lung fibrosis. This project is intended to develop therapies for people suffering from Covid-19’s long-term effects.
Innovation S-curve for Internet of Things in the pharmaceutical industry Nanoparticles for drugdelivery is a key innovation A nanoparticle is a small particle ranging in size from 1 to 100 nanometres. Nanoparticles are used as novel drugdeliverysystems to deliver drugs to specific tissues and to provide controlled release therapy.
Available in a range of sizes, the company’s proprietary rubber compounds such as FM257 and FM457 are used in drugdeliverysystems by some of the world’s largest pharmaceutical organisations. This is where Datwyler, a leading provider of high-quality elastomer components, has focused much innovation.
Robotics, for example, has facilitated the automation of medicine preparation and distribution, controlled drugdeliverysystems, and machine-readable coding on medicine packages. Newly emerging technologies have helped in improving the effectiveness and safety of non-sterile commercial dose products.
There is also research being conducted on intracellular drugdelivery molecules to treat CVDs. It is a copolymer of PLA and PGA and is currently being tested for drugdeliverysystems for intractable disease including cardiovascular diseases. million lives each year. But that’s not all.
Data indicates that the global nanopharmaceutical drugs market size reached USD 53.85 According to GlobalData’s Nanopharmaceuticals Thematic Research report, the vast majority of marketed and pipeline nanopharmaceuticals are being used to treat a wide range of cancer indications, highlighting the ongoing unmet needs in this area.
However, research related to metabolites is essential to increase the understanding of molecular level interactions, functions, modifications and regulations in cells, therefore, the field of metabolomics plays a vital role in biomarker discovery for early disease diagnosis and prognosis as well as for drug discovery and development processes.
The VTT Technical Research Centre of Finland has addressed this issue by developing a fully recyclable, modular ECG patch constructed from VTT’s novel cellulose e-skin material. Aayush Jaiswal, research scientist at VTT said, “Ours is the first nanocellulose-based ECG patch with no plastic additives.
Over the years, applications of exosomes in therapeutics have undergone an evolutionary change, in terms of cost of research, technology used, and duration of the study. Published Scientific Literature: Indicative of the Ongoing pace of Research in this Field. Our Social Media Platform. Web: [link]. LinkedIn: [link]. Twitter: [link].
Clinical trials are the backbone of medical research, paving the way for new treatments, drugs, and therapeutic procedures that can potentially revolutionize healthcare. A Data Safety Monitoring Board (DSMB) is an independent committee composed of clinical research experts, statisticians, and often, ethicists.
Below are the highlights that we feel would be helpful to understand about the intracellular drugdelivery / intracellular non-viral drugdelivery approach. WHAT IS INTRACELLULAR DRUGDELIVERY? The main issues with viral delivery approach are the immunogenicity and cytotoxicity.
Over time, many research studies have shown that myeloid cells can interact with the immune system and aid in generating an appropriate anti-tumor immune response. Over 10,000 articles, indicative of the ongoing research and innovation in this field, have been published in scientific literature. ACADEMIC GRANTS ANALYSIS.
Likewise, there are several other targets that have not yet been successfully drugged and researchers are making significant efforts to identify novel approaches to target them. As a result, novel product development opportunities have emerged and are likely to benefit both drug developers and investors alike.
In recent years, liposomes have garnered significant interest of researchers, as well as industry players, owing to their potential in diagnosis and treatment of various diseases, with a focus on delivering drugs and genetic material. Majority of the articles (51%) are focused on evaluating liposomes for use in cancer therapy.
In the 20 th century, major research went into discovery of a therapeutic class with the primary purpose of interfering with the RNA expression linked to disease causing proteins, nowadays classified as oligonucleotides. Till date, 14 oligonucleotide-based therapies have been approved. Our Social Media Platform. Web: [link]. LinkedIn: [link].
In addition to therapeutics, these complex molecules act as a significant resource in various research applications. You may also be interested in the following titles: Live Biotherapeutic Products and Microbiome Manufacturing Marke t Next Generation Complement Therapeutics Market Intranasal Therapeutics and DrugDeliverySystems Market.
Application of Synthetic mRNA Several studies conducted by healthcare companies and research institutions have demonstrated the potential of mRNA. Additionally, they also require appropriate drugdeliverysystems to efficiently administer the intervention (in a manner that they can avoid degradation by cellular endonucleases).
Published Scientific Literature: Indicative of the Ongoing pace of Research in this Field. High Number of Patents are Suggestive of the Widespread Research in this Domain. Next Generation Complement Therapeutics. Next Generation Complement Therapeutics. For further information on this domain, check out the report –. Web: [link].
With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. million adults in the United States.
Certain areas where this technology is working hand-in-hand with healthcare are: Unsustainable healthcare systems into sustainable ones Equalizing the relationship between medical professionals and patient Provide cheaper, faster and more effective solutions for diseases. Healthcare Technology Utility in Different Platforms. Nanotechnology.
Oral Protein / Peptide-based Drugs. Clinical Research Landscape of Oral Peptide and Protein-based Therapeutics. You may also be interested in the following titles: Live Biotherapeutic Products and Microbiome Manufacturing Marke t Next Generation Complement Therapeutics Market Intranasal Therapeutics and DrugDeliverySystems Market.
A Retrospective Analysis: Visual Field Progression and Visual Acuity following Administration of Brimonidine DrugDeliverySystem. DURYSTA is an ophthalmic drugdeliverysystem for a single intracameral administration of a biodegradable implant containing 10 mcg bimatoprost. NORTH CHICAGO, Ill.
Amidst the current initiatives to develop therapeutic interventions with improved bioavailability, nanoparticles have specifically captured the interest of researchers and drug developers, given their ability to act as drug carriers for complex and highly promising therapeutics. Our Social Media Platform. Web: [link].
Drugs such as pembrolizumab (Merck’s Keytruda) and nivolumab (Bristol Myers Squibb’s Opdivo) have revolutionized the treatment options for skin cancer. Ongoing research on molecular diagnostics and AI-powered diagnostic tools has helped enhance the early detection and treatment of skin cancer, promising improved patient outcomes.
During our research, we identified over 40 players that offer manufacturing services of biopharmaceutical excipients. With outsourcing being increasingly accepted as a viable and beneficial business model within this field, we anticipate the biopharmaceutical excipient manufacturing market to grow at a steady pace in the coming years.
Real World Data and Blue Ocean Strategy Real-world data is particularly useful for researchers, as it provides valuable insights from patient data and knowledge that can impact many decision-making processes. Ronit holds a B.
Therapies such as dexamethasone drugdeliverysystem and vascular endothelial growth factor inhibitors have already pierced deeper into the market. The post Top Emerging Therapies To Watch Out for in the Retinal Vein Occlusion Market appeared first on DelveInsight Business Research.
Driven by the increasing need for safe and efficient medical devices and drugdeliverysystems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. There has been a rise in the development of polymers for biopharma with improved biocompatibility, biodegradability and functionality.
The light in the tunnel is mainly beaming due to the entry of recent treatment approaches that will add to the revenue of the present Retinal vein occlusion market which is heavily dominated by dexamethasone drugdeliverysystem and vascular endothelial growth factor inhibitors.
Conjugation with a Variety of Molecular Conjugates and Labels The combination of the conjugates / labels with molecules ( proteins, peptides, antibodies and small molecules ) is being used abundantly for several applications, ranging from therapeutics and diagnostics to isolation and characterization of drugdeliverysystems.
Vice President, Late Development and Global Medical Affairs, Janssen Research & Development, LLC. “We TAR-200 is an investigational drugdeliverysystem, enabling controlled release of gemcitabine into the bladder, increasing dwell time and local drug exposure. For more information, visit www.ERLEADA.com.
Amidst the ongoing initiatives to develop therapeutic interventions with improved bioavailability, lipid nanoparticle (LNPs) have specifically attracted the attention of researchers and drug developers. The LNPs can be monitored using various imaging modalities to confirm the delivery of siRNA to the target cells.
Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. In a recent webinar, Dr. Vornov described the history and current progress in targeted CNS therapeutic delivery. Viral Vectors for Gene Delivery to the CNS.
In 1974, Dr. Robert Langer was part of the first cohort of researchers to begin nanoparticle research , as his lab at Cornell University developed tiny particles to deliver large molecules for angiogenesis. The next wave came from early research into liposomes and lipid nanoparticles, both of which are used for drugdelivery.
A robust drug patent portfolio is not just an assetit’s a critical tool for success. As companies invest billions in research and development, protecting their innovations through strategic patent management has become more important than ever.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content